management of lupus nephritis

Clicks: 194
ID: 189750
2000
Summary : Renal disease is common in systemic lupus erythematosus (SLE) and significantly influences patient prognosis. Immunosuppressive therapy has markedly improved outcome, however, it increases the risk of infection and cancer induction. Although several therapeutic regimens have proved to be effective in controlling lupus nephritis (LN), optimal therapy is still a matter of discussion. The following review summarizes our current knowledge in treating LN and discusses new aspects in pathogenesis. Hopefully, continuing progress in uncovering details about the pathogenesis of SLE might lead to more disease-specific approaches to treat the underlying immunological disorder.
Reference Key
f2000saudimanagement Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Merkel F;Gross O;Weber M
Journal 15th ibero-american conference on software engineering, cibse 2012
Year 2000
DOI DOI not found
URL
http://www.sjkdt.org/article.asp?issn=1319-2442;year=2000;volume=11;issue=3;spage=381;epage=395;aulast=Merkel
Keywords
Medicine systemic lupus erythematosus autoimmunity glomerulonephritis immunosuppressive therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.